Global Injectable Anthelmintic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 88

Published Date: 11 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Injectable Anthelmintic Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Injectable Anthelmintic Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Injectable Anthelmintic Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Injectable Anthelmintic Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Injectable Anthelmintic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Injectable Anthelmintic Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Injectable Anthelmintic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Injectable Anthelmintic Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals and Zoetis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Injectable Anthelmintic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Benzimidazoles
    Piperazine
    Imidazothiazole
    Spiroindoles
    Others

Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Veterinary Pharmacies
    Others

Market segment by players, this report covers
    Novartis
    Cipla
    Sun Pharmaceutical Industries
    Amneal Pharmaceuticals
    Zoetis
    GlaxoSmithKline
    Bayer
    Merck
    Boehringer Ingelheim International

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Injectable Anthelmintic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Injectable Anthelmintic Drugs, with revenue, gross margin and global market share of Injectable Anthelmintic Drugs from 2018 to 2023.
Chapter 3, the Injectable Anthelmintic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Injectable Anthelmintic Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Anthelmintic Drugs.
Chapter 13, to describe Injectable Anthelmintic Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Injectable Anthelmintic Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Injectable Anthelmintic Drugs by Type
        1.3.1 Overview: Global Injectable Anthelmintic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Injectable Anthelmintic Drugs Consumption Value Market Share by Type in 2022
        1.3.3 Benzimidazoles
        1.3.4 Piperazine
        1.3.5 Imidazothiazole
        1.3.6 Spiroindoles
        1.3.7 Others
    1.4 Global Injectable Anthelmintic Drugs Market by Application
        1.4.1 Overview: Global Injectable Anthelmintic Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
        1.4.5 Veterinary Pharmacies
        1.4.6 Others
    1.5 Global Injectable Anthelmintic Drugs Market Size & Forecast
    1.6 Global Injectable Anthelmintic Drugs Market Size and Forecast by Region
        1.6.1 Global Injectable Anthelmintic Drugs Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Injectable Anthelmintic Drugs Market Size by Region, (2018-2029)
        1.6.3 North America Injectable Anthelmintic Drugs Market Size and Prospect (2018-2029)
        1.6.4 Europe Injectable Anthelmintic Drugs Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Injectable Anthelmintic Drugs Market Size and Prospect (2018-2029)
        1.6.6 South America Injectable Anthelmintic Drugs Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Injectable Anthelmintic Drugs Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Injectable Anthelmintic Drugs Product and Solutions
        2.1.4 Novartis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Cipla
        2.2.1 Cipla Details
        2.2.2 Cipla Major Business
        2.2.3 Cipla Injectable Anthelmintic Drugs Product and Solutions
        2.2.4 Cipla Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Cipla Recent Developments and Future Plans
    2.3 Sun Pharmaceutical Industries
        2.3.1 Sun Pharmaceutical Industries Details
        2.3.2 Sun Pharmaceutical Industries Major Business
        2.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product and Solutions
        2.3.4 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
    2.4 Amneal Pharmaceuticals
        2.4.1 Amneal Pharmaceuticals Details
        2.4.2 Amneal Pharmaceuticals Major Business
        2.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product and Solutions
        2.4.4 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Amneal Pharmaceuticals Recent Developments and Future Plans
    2.5 Zoetis
        2.5.1 Zoetis Details
        2.5.2 Zoetis Major Business
        2.5.3 Zoetis Injectable Anthelmintic Drugs Product and Solutions
        2.5.4 Zoetis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Zoetis Recent Developments and Future Plans
    2.6 GlaxoSmithKline
        2.6.1 GlaxoSmithKline Details
        2.6.2 GlaxoSmithKline Major Business
        2.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Product and Solutions
        2.6.4 GlaxoSmithKline Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 GlaxoSmithKline Recent Developments and Future Plans
    2.7 Bayer
        2.7.1 Bayer Details
        2.7.2 Bayer Major Business
        2.7.3 Bayer Injectable Anthelmintic Drugs Product and Solutions
        2.7.4 Bayer Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Bayer Recent Developments and Future Plans
    2.8 Merck
        2.8.1 Merck Details
        2.8.2 Merck Major Business
        2.8.3 Merck Injectable Anthelmintic Drugs Product and Solutions
        2.8.4 Merck Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Merck Recent Developments and Future Plans
    2.9 Boehringer Ingelheim International
        2.9.1 Boehringer Ingelheim International Details
        2.9.2 Boehringer Ingelheim International Major Business
        2.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Product and Solutions
        2.9.4 Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Boehringer Ingelheim International Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Injectable Anthelmintic Drugs Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Injectable Anthelmintic Drugs by Company Revenue
        3.2.2 Top 3 Injectable Anthelmintic Drugs Players Market Share in 2022
        3.2.3 Top 6 Injectable Anthelmintic Drugs Players Market Share in 2022
    3.3 Injectable Anthelmintic Drugs Market: Overall Company Footprint Analysis
        3.3.1 Injectable Anthelmintic Drugs Market: Region Footprint
        3.3.2 Injectable Anthelmintic Drugs Market: Company Product Type Footprint
        3.3.3 Injectable Anthelmintic Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Injectable Anthelmintic Drugs Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Injectable Anthelmintic Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Injectable Anthelmintic Drugs Consumption Value Market Share by Application (2018-2023)
    5.2 Global Injectable Anthelmintic Drugs Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Injectable Anthelmintic Drugs Consumption Value by Type (2018-2029)
    6.2 North America Injectable Anthelmintic Drugs Consumption Value by Application (2018-2029)
    6.3 North America Injectable Anthelmintic Drugs Market Size by Country
        6.3.1 North America Injectable Anthelmintic Drugs Consumption Value by Country (2018-2029)
        6.3.2 United States Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        6.3.3 Canada Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        6.3.4 Mexico Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Injectable Anthelmintic Drugs Consumption Value by Type (2018-2029)
    7.2 Europe Injectable Anthelmintic Drugs Consumption Value by Application (2018-2029)
    7.3 Europe Injectable Anthelmintic Drugs Market Size by Country
        7.3.1 Europe Injectable Anthelmintic Drugs Consumption Value by Country (2018-2029)
        7.3.2 Germany Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        7.3.3 France Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        7.3.5 Russia Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        7.3.6 Italy Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region
        8.3.1 Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Region (2018-2029)
        8.3.2 China Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        8.3.3 Japan Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        8.3.4 South Korea Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        8.3.5 India Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        8.3.7 Australia Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Injectable Anthelmintic Drugs Consumption Value by Type (2018-2029)
    9.2 South America Injectable Anthelmintic Drugs Consumption Value by Application (2018-2029)
    9.3 South America Injectable Anthelmintic Drugs Market Size by Country
        9.3.1 South America Injectable Anthelmintic Drugs Consumption Value by Country (2018-2029)
        9.3.2 Brazil Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        9.3.3 Argentina Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country
        10.3.1 Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Country (2018-2029)
        10.3.2 Turkey Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)
        10.3.4 UAE Injectable Anthelmintic Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Injectable Anthelmintic Drugs Market Drivers
    11.2 Injectable Anthelmintic Drugs Market Restraints
    11.3 Injectable Anthelmintic Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Injectable Anthelmintic Drugs Industry Chain
    12.2 Injectable Anthelmintic Drugs Upstream Analysis
    12.3 Injectable Anthelmintic Drugs Midstream Analysis
    12.4 Injectable Anthelmintic Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Injectable Anthelmintic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Injectable Anthelmintic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Injectable Anthelmintic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Injectable Anthelmintic Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Novartis Company Information, Head Office, and Major Competitors
    Table 6. Novartis Major Business
    Table 7. Novartis Injectable Anthelmintic Drugs Product and Solutions
    Table 8. Novartis Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Novartis Recent Developments and Future Plans
    Table 10. Cipla Company Information, Head Office, and Major Competitors
    Table 11. Cipla Major Business
    Table 12. Cipla Injectable Anthelmintic Drugs Product and Solutions
    Table 13. Cipla Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Cipla Recent Developments and Future Plans
    Table 15. Sun Pharmaceutical Industries Company Information, Head Office, and Major Competitors
    Table 16. Sun Pharmaceutical Industries Major Business
    Table 17. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product and Solutions
    Table 18. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Sun Pharmaceutical Industries Recent Developments and Future Plans
    Table 20. Amneal Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 21. Amneal Pharmaceuticals Major Business
    Table 22. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product and Solutions
    Table 23. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Amneal Pharmaceuticals Recent Developments and Future Plans
    Table 25. Zoetis Company Information, Head Office, and Major Competitors
    Table 26. Zoetis Major Business
    Table 27. Zoetis Injectable Anthelmintic Drugs Product and Solutions
    Table 28. Zoetis Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Zoetis Recent Developments and Future Plans
    Table 30. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 31. GlaxoSmithKline Major Business
    Table 32. GlaxoSmithKline Injectable Anthelmintic Drugs Product and Solutions
    Table 33. GlaxoSmithKline Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. GlaxoSmithKline Recent Developments and Future Plans
    Table 35. Bayer Company Information, Head Office, and Major Competitors
    Table 36. Bayer Major Business
    Table 37. Bayer Injectable Anthelmintic Drugs Product and Solutions
    Table 38. Bayer Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Bayer Recent Developments and Future Plans
    Table 40. Merck Company Information, Head Office, and Major Competitors
    Table 41. Merck Major Business
    Table 42. Merck Injectable Anthelmintic Drugs Product and Solutions
    Table 43. Merck Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Merck Recent Developments and Future Plans
    Table 45. Boehringer Ingelheim International Company Information, Head Office, and Major Competitors
    Table 46. Boehringer Ingelheim International Major Business
    Table 47. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product and Solutions
    Table 48. Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Boehringer Ingelheim International Recent Developments and Future Plans
    Table 50. Global Injectable Anthelmintic Drugs Revenue (USD Million) by Players (2018-2023)
    Table 51. Global Injectable Anthelmintic Drugs Revenue Share by Players (2018-2023)
    Table 52. Breakdown of Injectable Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in Injectable Anthelmintic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 54. Head Office of Key Injectable Anthelmintic Drugs Players
    Table 55. Injectable Anthelmintic Drugs Market: Company Product Type Footprint
    Table 56. Injectable Anthelmintic Drugs Market: Company Product Application Footprint
    Table 57. Injectable Anthelmintic Drugs New Market Entrants and Barriers to Market Entry
    Table 58. Injectable Anthelmintic Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global Injectable Anthelmintic Drugs Consumption Value (USD Million) by Type (2018-2023)
    Table 60. Global Injectable Anthelmintic Drugs Consumption Value Share by Type (2018-2023)
    Table 61. Global Injectable Anthelmintic Drugs Consumption Value Forecast by Type (2024-2029)
    Table 62. Global Injectable Anthelmintic Drugs Consumption Value by Application (2018-2023)
    Table 63. Global Injectable Anthelmintic Drugs Consumption Value Forecast by Application (2024-2029)
    Table 64. North America Injectable Anthelmintic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 65. North America Injectable Anthelmintic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 66. North America Injectable Anthelmintic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. North America Injectable Anthelmintic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. North America Injectable Anthelmintic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 69. North America Injectable Anthelmintic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 70. Europe Injectable Anthelmintic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Europe Injectable Anthelmintic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Europe Injectable Anthelmintic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 73. Europe Injectable Anthelmintic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 74. Europe Injectable Anthelmintic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Injectable Anthelmintic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 77. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 78. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 79. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 80. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 81. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 82. South America Injectable Anthelmintic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 83. South America Injectable Anthelmintic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 84. South America Injectable Anthelmintic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 85. South America Injectable Anthelmintic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 86. South America Injectable Anthelmintic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. South America Injectable Anthelmintic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 89. Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 90. Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 91. Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 93. Middle East & Africa Injectable Anthelmintic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 94. Injectable Anthelmintic Drugs Raw Material
    Table 95. Key Suppliers of Injectable Anthelmintic Drugs Raw Materials
List of Figures
    Figure 1. Injectable Anthelmintic Drugs Picture
    Figure 2. Global Injectable Anthelmintic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Injectable Anthelmintic Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Benzimidazoles
    Figure 5. Piperazine
    Figure 6. Imidazothiazole
    Figure 7. Spiroindoles
    Figure 8. Others
    Figure 9. Global Injectable Anthelmintic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Injectable Anthelmintic Drugs Consumption Value Market Share by Application in 2022
    Figure 11. Hospital Pharmacies Picture
    Figure 12. Retail Pharmacies Picture
    Figure 13. Online Pharmacies Picture
    Figure 14. Veterinary Pharmacies Picture
    Figure 15. Others Picture
    Figure 16. Global Injectable Anthelmintic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 17. Global Injectable Anthelmintic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 18. Global Market Injectable Anthelmintic Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 19. Global Injectable Anthelmintic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 20. Global Injectable Anthelmintic Drugs Consumption Value Market Share by Region in 2022
    Figure 21. North America Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East and Africa Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Injectable Anthelmintic Drugs Revenue Share by Players in 2022
    Figure 27. Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 28. Global Top 3 Players Injectable Anthelmintic Drugs Market Share in 2022
    Figure 29. Global Top 6 Players Injectable Anthelmintic Drugs Market Share in 2022
    Figure 30. Global Injectable Anthelmintic Drugs Consumption Value Share by Type (2018-2023)
    Figure 31. Global Injectable Anthelmintic Drugs Market Share Forecast by Type (2024-2029)
    Figure 32. Global Injectable Anthelmintic Drugs Consumption Value Share by Application (2018-2023)
    Figure 33. Global Injectable Anthelmintic Drugs Market Share Forecast by Application (2024-2029)
    Figure 34. North America Injectable Anthelmintic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 35. North America Injectable Anthelmintic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 36. North America Injectable Anthelmintic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 38. Canada Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 39. Mexico Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 40. Europe Injectable Anthelmintic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 41. Europe Injectable Anthelmintic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 42. Europe Injectable Anthelmintic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 44. France Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 45. United Kingdom Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 46. Russia Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 47. Italy Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Injectable Anthelmintic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 51. China Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 52. Japan Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 53. South Korea Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 54. India Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 55. Southeast Asia Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 56. Australia Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 57. South America Injectable Anthelmintic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 58. South America Injectable Anthelmintic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 59. South America Injectable Anthelmintic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 60. Brazil Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 61. Argentina Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 62. Middle East and Africa Injectable Anthelmintic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 63. Middle East and Africa Injectable Anthelmintic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 64. Middle East and Africa Injectable Anthelmintic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 65. Turkey Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 66. Saudi Arabia Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 67. UAE Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 68. Injectable Anthelmintic Drugs Market Drivers
    Figure 69. Injectable Anthelmintic Drugs Market Restraints
    Figure 70. Injectable Anthelmintic Drugs Market Trends
    Figure 71. Porters Five Forces Analysis
    Figure 72. Manufacturing Cost Structure Analysis of Injectable Anthelmintic Drugs in 2022
    Figure 73. Manufacturing Process Analysis of Injectable Anthelmintic Drugs
    Figure 74. Injectable Anthelmintic Drugs Industrial Chain
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International

Related Reports

Global Injectable Anthelmintic Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Injectable Anthelmintic Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 04 Mar 2021

date Medical Care

The Injectable Anthelmintic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Injectable Anthelmintic Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Injectable Anthelmintic Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Medical Care

Global Injectable Anthelmintic Drugs Supply, Demand and Key Producers, 2023-2029

Global Injectable Anthelmintic Drugs Supply, Demand and Key Producers, 2023-2029

date 24 Jan 2023

date Medical Care

The global Injectable Anthelmintic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Injectable Anthelmintic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Injectable Anthelmintic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 07 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Injectable Anthelmintic Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Injectable Anthelmintic Drugs Supply, Demand and Key Producers, 2024-2030

Global Injectable Anthelmintic Drugs Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Medical Care

The global Injectable Anthelmintic Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

injectable anthelmintic drugs

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>